NasdaqCM - Nasdaq Real Time Price USD
Galecto, Inc. (GLTO)
At close: October 21 at 4:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHRISTGAU STEPHAN Director | Purchase | Nov 2, 2020 | -- |
| FREVE JONATHAN Chief Financial Officer | Purchase | Dec 3, 2021 | 12,000 |
| KHUONG CHAU QUANG Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Nov 2, 2020 | -- |
| LINDMARK BERTIL Officer | Purchase | Mar 22, 2022 | 16,604 |
| MUNSHI AMIT D Director | Conversion of Exercise of derivative security | Nov 2, 2020 | 4,793 |
| NOVO HOLDINGS A/S Beneficial Owner of more than 10% of a Class of Security | Purchase | Nov 2, 2020 | 2,497,790 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 15, 2023 | -- |
| PEDERSEN ANDERS Chief Operating Officer | Conversion of Exercise of derivative security | Nov 2, 2020 | 3,746 |
| SCHAMBYE HANS T. Chief Executive Officer | Purchase | Mar 22, 2022 | 52,428 |
| WINSLOW GARRETT General Counsel | Purchase | Dec 3, 2021 | 4,000 |
Related Tickers
ASMB Assembly Biosciences, Inc.
16.59
-9.05%
SEER Seer, Inc.
1.9100
-1.04%
TBPH Theravance Biopharma, Inc.
8.66
-1.59%
SPRO Spero Therapeutics, Inc.
1.2800
0.00%
HLVX HilleVax, Inc.
1.8300
-2.66%
BOLT Bolt Biotherapeutics, Inc.
0.6376
+1.79%
OKUR OnKure Therapeutics, Inc.
18.55
+0.22%
VTYX Ventyx Biosciences, Inc.
2.3900
-5.91%
ANTX AN2 Therapeutics, Inc.
1.0800
+2.86%
CLRB Cellectar Biosciences, Inc.
2.1100
+0.96%